ASCO and NCCN have worked together to help clinicians and patients identify and treat the side effects of immunotherapy before they become dangerous. Doctor and patient advocate Laura Porter describes what to watch out for if you’re taking an immune checkpoint inhibitor, a type of immunotherapy, for cancer.
The 2018 Cancer Survivorship Symposium: Advancing Care and Research will address key issues in promoting well-being in people who have finished active cancer treatment, covering topics such as exercise, follow-up care in young adult survivors, and better support for sexual problems.
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?
In this podcast, Dr. Erica Mayer reviews research highlights from the San Antonio Breast Cancer Symposium. New insights into hormone therapy, targeted therapy, joint stiffness, and fertility preservation are covered.
Many cancer treatments can cause hair loss (alopecia). Talking with your health care team, learning about resources and programs, and finding support in your community can help you cope with hair loss.
After androgen-deprivation therapy for prostate cancer, many couples are surprised by the physical and emotional changes that come into their relationship because of a lack of testosterone.
The mouth is a complex body part, and cancer treatment can affect it. Here are some tips for oral hygiene and keeping your mouth healthy before and during treatment.
Research Round Up Podcast: Managing Side Effects, Breast Cancer, Chronic Myeloid Leukemia, and Myeloma
Cancer.Net Associate Editors discuss exciting new cancer research in the final Research Round Up podcast of the summer.
In this podcast from the ASCO Educational Book, Dr. Judith A. Paice discusses the risks and benefits of using opioids for pain caused by cancer and its treatment.
ASCO Annual Meeting 2017: Advances in Immunotherapy for Multiple Myeloma and Mesothelioma, and Targeted Therapies for Non-Small Cell Lung Cancer and HER2-Positive Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.